Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

26. Januar 2026 06:05 ET | Quelle: MannKind

MannKind Announces FDA Approval of Updated Afrezza® Label Providing Starting Dose Guidance when Switching from Multiple Daily Injections (MDI) or Insulin Pump Mealtime Therapy

MannKind Announces FDA Approval of Updated Afrezza® Label Providing Starting Dose Guidance when Switching from Multiple Daily Injections (MDI) or Insulin
22. Januar 2026 04:17 ET | Quelle: Research and Markets

Global Needle-Free Diabetes Care Market Set to Reach USD 19.88 Billion by 2032, Revolutionizing Chronic Disease Management

Dublin, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The "Needle Free Diabetes Care Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.The Needle Free Diabetes Care Market...
20. Januar 2026 03:00 ET | Quelle: Nxera Pharma

Nxera Pharma Establishes Metabolic Advisory Council to Advance Next-Generation Therapies for Obesity and Metabolic Disorders

Council brings together leading global scientific and clinical experts in metabolic diseases to guide development of Nxera’s expanding proprietary pipeline Tokyo, Japan and Cambridge, UK, 20...
15. Januar 2026 09:31 ET | Quelle: The Juvenile Diabetes Cure Alliance

14th Annual State of the Cure for T1D Shows Major Development in Cure Research

NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Juvenile Diabetes Cure Alliance (JDCA), a 501(c)(3) nonprofit solely focused on accelerating a cure for type 1 diabetes, announced the release of the 14th...
14. Januar 2026 07:15 ET | Quelle: Glucose Health

Glucose Health, Inc. Reports Debt-Free Balance Sheet and Previews New Soluble Fiber Brand

BENTONVILLE, Ark., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC), a consumer-health company specializing in soluble-fiber nutrition products for metabolic support, today...
07. Januar 2026 07:15 ET | Quelle: Glucose Health

Glucose Health, Inc. Board Members Confirm Participation in Preferred Share Conversion at 85% Premium to Market and Introduce New Revenue Growth Strategy

BENTONVILLE, Ark., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC), a consumer-health company specializing in soluble-fiber nutrition products for metabolic support, today...
18. Dezember 2025 09:00 ET | Quelle: American Kidney Fund

American Kidney Fund Teams Up with the American Diabetes Association to Increase Awareness of the Intersection of Kidney Disease and Diabetes

ROCKVILLE, Md., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) is pleased to announce that it is joining forces with the American Diabetes Association® (ADA) to increase...
18. Dezember 2025 08:30 ET | Quelle: Biodexa Pharmaceuticals PLC

Biodexa Announces Pricing of $10 Million Public Offering

December 18, 2025 Biodexa Announces Pricing of $10 Million Public Offering Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX) (“Biodexa” or the “Company”), a clinical stage biopharmaceutical company...
18. Dezember 2025 02:00 ET | Quelle: GlucoModicum

GlucoModicum unveils Sofio™, the world’s first needle-free glucose monitor based on magneto-hydrodynamics (MHD)

PRESS RELEASE — FOR IMMEDIATE RELEASE GlucoModicum unveils Sofio™, the world’s first needle-free glucose monitor based on magneto-hydrodynamics (MHD) MHD technology draws micro-sample through skin;...
16. Dezember 2025 12:00 ET | Quelle: USA News Group

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and...

Nächste Seite